HOME >> MEDICINE >> NEWS
Deakin University has developed a prototype tasty snack food with special health benefits

Dr Russell Keast, a senior lecturer in the school of exercise and nutrition sciences, has developed a new snack food with a parmesan cheese cracker, organic mashed potato and special healthy additives.

He said, "This new snack has natural additives such as an anti-inflammatory agent, omega 3 fatty acids and zinc to improve brain and heart function, boost male virility and improve immunity."

Dr Keast said it was the first time the anti-inflammatory agent oleocanthal had been included in a manufactured food and research was continuing into its flavour and health promoting properties.

A natural appetite suppressant which makes the consumer feel fuller for longer, and a natural compound to increase liking for a product, have also been added to the snack food.

Samples of the snack are being presented to the food industry at a workshop at Deakin University to point the way to healthy snacks of the future.

"Overall, the snack is a vehicle for these health promoting compounds. However, it must be flavorsome and popular so people will want to eat it repeatedly," Dr Keast said.

"An agent in the snack will help prevent overeating it.

"While it is not a natural food, it is an innovative food."

Professor Andrew Sinclair, Chair in Human Nutrition in the School of Exercise and Nutrition Sciences, said the workshop aimed to bring together leaders in marketing, product development, researchers and educators, with Deakin University experts.

The workshop will be held at Deakin University's Burwood campus, Building X, Lecture Theatre 12 from 8.30am. Registration is limited to 100 places.


'"/>

Contact: Dr. Russell Keast
61-392-446-944
Research Australia
25-Jun-2006


Page: 1

Related medicine news :

1. Indiana University Imaging Center receives $6M grant for kidney research
2. University hospitals wins multiple national IT awards for electronic patient data bank
3. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
4. University research wins royal accolade
5. New Orleans levee report finished by panel including University of Texas at Austin engineer
6. Boston University School of Medicine faculty member receives honorary degree from alma mater
7. NY-Presbyterian Hospital/Columbia University Medical Center doctors present at 2007 AUA Meeting
8. Emory University researchers find persistent and severe asthma associated with obesity
9. Mid Sweden University leads development of digital color x-rays
10. $2.6M grant awarded to New York University College of Nursing
11. Baby aspirin better for your health, University of Kentucky study says

Post Your Comments:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Transvaginal ... Bard, Inc., continue to move forward in a federal ... of West Virginia, Bernstein Liebhard LLP reports. In ... a request by C.R. Bard to seal emails that ... secrets and other confidential, proprietary information about its suppliers. ...
(Date:5/23/2013)... 23, 2013 Click here to read ... start-ups are increasingly seeing their success develop through ... companies, according to new research carried out by ... The company has compiled its research into a series ... of the research have shown the general trend that ...
(Date:5/23/2013)... EnvirOasis, the leader in energy efficient lighting retrofit ... to announce its new line of Energy Star and ... has been a market leader in Fluorescent and ... recently brought to market a full line of LED ... efficient lighting technology which produces a very high light ...
(Date:5/23/2013)... Reporter , , THURSDAY, May 23 (HealthDay News) -- Heavy ... as methamphetamine or crack cocaine, a new study contends. ... or ,coke mouth, it is startling to see the ... same," said Dr. Mohamed Bassiouny, a professor of restorative ... Philadelphia. Methamphetamine, crack cocaine and soda -- sweetened ...
(Date:5/23/2013)... . University ... that can potentially slow the progression of some cancers ... 23 edition of the prestigious journal Cell , ... found that the anti-cancer and anti-proliferative drug rapamycin slows ... monitor the availability of nutrients and will slow down ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 2Health News:Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Order in Federal C.R. Bard Mesh Implant Lawsuits 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 2Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 3Health News:Merrill DataSite Releases New Comments: Trends amidst Canadian and US Tech M&A 4Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists discover how rapamycin slows cell growth 2
(Date:5/23/2013)... SANTA MONICA, Calif. , May 23, 2013 /PRNewswire-USNewswire/ ... of a program that would have required them to ... announced today by Consumer Watchdog and Whatley Kallas LLC.  ... San Diego Superior Court, alleged that Blue Cross,s mandatory ... HIV/AIDS patients, threatening their health and privacy. ...
(Date:5/23/2013)... 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company ... today announced that it has initiated dosing in a ... daily, oral therapy for the treatment of HCV infection. This ... is designed to assess both the safety and antiviral ... drug for the treatment of chronic HCV infections and ...
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
Breaking Medicine Technology:Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2
Cached News: